Multiparametric MRI for Characterization of Hepatocellular Carcinoma
Recruiting
Observational Study
Hepatocellular Carcinoma (HCC)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 128 (estimated)
- Sponsor
- University Hospital Muenster · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This prospective observational study investigates using multiparametric magnetic resonance imaging (MRI) to improve the characterization and management of therapy for hepatocellular carcinoma (HCC). The goal is to evaluate whether advanced MRI parameters can support noninvasive diagnostic assessments and personalized treatment plans for patients with HCC. The study is being conducted at a single u…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥18 years
* Confirmed or suspected diagnosis of HCC
* Scheduled to receive TACE or SIRT as part of standard clinical care
* Eligibility for liver MRI
* Willing and able to provide written informed consent
Exclusion Criteria:
* Contraindications to MRI (e.g., pacemakers, …
Contacts